You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
國內疫情多處散點發生推動新冠檢測股拉昇,安旭生物、九安醫療等多股漲停
格隆匯1月11日丨延續昨日強勢,新冠檢測概念股今日再度拉昇。天瑞儀器、亞輝龍、塞力醫療、安旭生物、九安醫療漲停。其中,安旭生物連續第四日漲停,公司表示,其新型冠狀病毒抗原鼻腔檢測試劑(自測)獲得歐盟CE認證。熱景生物、博拓生物、科華生物等集體大漲。除了國外疫情高發助推新冠檢測試劑價格暴漲外,近日新冠疫情在國內包括陝西、河南、深圳、天津等多省份、城市出現散點發生,也使得新冠檢測試劑需求量大增,其中天津出現奧密克戎本土病例。有媒體稱,包括東方生物、安旭生物在內的多家新冠檢測試劑公司臨時大量招募工人保障生產。中國疾控中心病毒預防控制所所長許文波曾在2021年11月30日舉行的國務院聯防聯控機制新聞發佈會上表示:“我國主流的核酸檢測試劑敏感性和特異性沒有變化,可以應對奧密克戎變異株的輸入。”目前,萬孚生物、東方生物等二十餘家新冠檢測生物公司均已公開表示,旗下已上市產品對奧密克戎變異株不會出現漏檢和脱靶的問題。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account